EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 16-Jun-2025 01:09 ET (16-Jun-2025 05:09 GMT/UTC)

Start-up EBViously founded

German Center for Infection Research
Business Announcement

EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV). The aim is to protect people from a range of serious diseases such as infectious mononucleosis, secondary diseases such as multiple sclerosis and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and certain types of cancer.

USC Norris Cancer Hospital earns Leapfrog Top Hospital award for fourth year in a row

University of Southern California - Health Sciences
Business Announcement

USC Norris Cancer Hospital was named a Top Teaching Hospital by The Leapfrog Group.

Scientists develop new scans that light-up aggressive cancer tumors for better treatment

King's College London
Peer-Reviewed Publication

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

Journal: Nature Communications

The longevity factor Foxo3 mediates “unfit” cell elimination to ensure healthy body construction

The University of Osaka
Peer-Reviewed Publication

Researchers from Osaka University have revealed some of the precise mechanisms by which erroneous cells are recognized, marked for removal, and eliminated via apoptosis in developing zebrafish. Notably, they found that the protein Foxo3 may be a universal marker of cell competition in zebrafish and mice. These findings have important implications for congenital disorders, cancer, and aging, and may lead to novel treatments.

Journal: Nature Communications
Funder: Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Japan Agency for Medical Research and Development

Sylvester Cancer Tip Sheet for Dec. 2024

University of Miami Miller School of Medicine
Reports and Proceedings

Advice for dealing with loss and holiday grief, a physician-scientist explains using “biological age” as a tool to predict early colorectal cancer risk, blood cancer experts share research insights that may one day lead to a cure for multiple myeloma, genetic mutations accumulate in smokers with MDS, using an antibody to treat high-risk forms of lymphoma and ongoing research seeks answers for higher breast cancer risk among Caribbean women.

$10.8 million grant supports cutting-edge leukemia research

WashU Medicine
Grant and Award Announcement

Washington University School of Medicine in St. Louis has been awarded a five-year, $10.8 million grant to further its exceptional programs in leukemia and other blood cancers. The grant, from the National Cancer Institute (NCI) of the National Institutes of Health (NIH), renews funding for a prestigious Specialized Program of Research Excellence (SPORE) in leukemia. The NCI’s SPORE program is designed to support translational research that moves discoveries from the lab to the clinic.

Study explores whether CBD can reduce scan-related anxiety in patients with advanced breast cancer

Brigham and Women's Hospital
Peer-Reviewed Publication

A new study conducted as a collaboration between researchers from Dana-Farber Cancer Institute and Mass General Brigham explores whether cannabidiol (CBD), a component of marijuana, can reduce anxiety levels, specifically among patients with advanced breast cancer before a scan assessing tumor burden.

Journal: JAMA Network Open
Funder: Hans and Mavis Lopater Foundation, Gloria Spivak Faculty Advancement Fund

Breakthrough in treatment approach showing promise in the fight against glioblastoma, the deadliest and most aggressive type of brain cancer

Mayo Clinic
Peer-Reviewed Publication

Mayo Clinic announces the results of an innovative treatment approach that may offer improvement in overall survival in older patients with newly diagnosed glioblastoma while maintaining quality of life. Glioblastoma is the most lethal type of primary brain cancer due to its aggressive nature and its treatment-resistant characteristics. It is the most common form of primary brain cancer.

Journal: The Lancet Oncology
Funder: Mayo Clinic Marley Endowment Funds, Lawrence W. and Marilyn W. Matteson Fund in Cancer Research

New drug shows promise against Duchenne muscular dystrophy

McGill University
Peer-Reviewed Publication

A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration.

McGill University researchers have discovered that an experimental compound called K884 can boost the natural repair abilities of muscle stem cells. Current treatments can slow muscle damage, but don’t address the root problem.

Journal: Life Science Alliance

VCU secures $9 million grant to establish Cancer Control Equity Research Center in Virginia

Virginia Commonwealth University
Grant and Award Announcement

Virginia Commonwealth University (VCU) has been awarded a five-year, $9 million grant from the National Cancer Institute to establish a pioneering Cancer Control Equity Research Center. This initiative aims to enhance the dissemination and implementation of health promotion and cancer prevention services for individuals and families residing in Virginia's Housing and Urban Development (HUD)-administered income-based housing communities in the Greater Richmond region and Hampton Roads.

Funder: NIH/National Cancer Institute